{"name":"TearScience","permalink":"tearscience","crunchbase_url":"http://www.crunchbase.com/company/tearscience","homepage_url":"http://www.tearscience.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"","description":"","created_at":"Fri May 07 04:50:43 UTC 2010","updated_at":"Fri May 07 04:50:42 UTC 2010","overview":"<p>&#8220;TearScience&#8217;s technology provides the most significant advancement in the past few decades toward the treatment of patients with evaporative dry eye problems. Based on clinical results, TearScience&#8217;s products have the potential to dramatically improve the quality of life for these patients.&#8221;</p>","image":{"available_sizes":[[[150,9],"assets/images/resized/0008/6329/86329v1-max-150x150.png"],[[250,16],"assets/images/resized/0008/6329/86329v1-max-250x250.png"],[[450,29],"assets/images/resized/0008/6329/86329v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$44.5M","funding_rounds":[{"round_code":"c","source_url":"http://onbiovc.com/tearscience-inc-series-c-445m/","source_description":"TearScience, Inc.: Series C $44.5M","raised_amount":44500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":6,"investments":[{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Investor Growth Capital","permalink":"investor-growth-capital","image":{"available_sizes":[[[107,31],"assets/images/resized/0002/9321/29321v1-max-150x150.png"],[[107,31],"assets/images/resized/0002/9321/29321v1-max-250x250.png"],[[107,31],"assets/images/resized/0002/9321/29321v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"General Catalyst Partners","permalink":"general-catalyst-partners","image":{"available_sizes":[[[150,35],"assets/images/resized/0017/6425/176425v1-max-150x150.png"],[[240,57],"assets/images/resized/0017/6425/176425v1-max-250x250.png"],[[240,57],"assets/images/resized/0017/6425/176425v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"De Novo Ventures","permalink":"de-novo-ventures","image":{"available_sizes":[[[140,77],"assets/images/resized/0004/5371/45371v1-max-150x150.jpg"],[[140,77],"assets/images/resized/0004/5371/45371v1-max-250x250.jpg"],[[140,77],"assets/images/resized/0004/5371/45371v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Spray Venture Partners","permalink":"spray-venture-partners","image":{"available_sizes":[[[121,138],"assets/images/resized/0006/2099/62099v1-max-150x150.jpg"],[[121,138],"assets/images/resized/0006/2099/62099v1-max-250x250.jpg"],[[121,138],"assets/images/resized/0006/2099/62099v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}